{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:01:52Z","timestamp":1747166512771,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jtumed.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T14:29:42Z","timestamp":1523024982000},"page":"483-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of recombinant tissue plasminogen activator for treatment of recalcitrant anterior uveitis: A case series"],"prefix":"10.1016","volume":"13","author":[{"given":"Sylves","family":"Patrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Hui-Tze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Hitam","family":"Wan-Hazabbah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Embong","family":"Zunaina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaakub","family":"Azhany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-8816","authenticated-orcid":false,"given":"Ahmad Tajudin","family":"Liza-Sharmini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jtumed.2018.03.005_bib1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ajo.2005.01.029","article-title":"The development of ccomplications in patients with chronic uveitis","volume":"139","author":"Menezo","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtumed.2018.03.005_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","article-title":"Ocular effects of topical and systemic steroids","volume":"10","author":"Renfro","year":"1992","journal-title":"Dermato Clin"},{"issue":"2","key":"10.1016\/j.jtumed.2018.03.005_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0950-3536(05)80268-9","article-title":"1 Mechanisms of physiological fibrinolysis","volume":"8","author":"Lijnen","year":"1995","journal-title":"Bailliere Clin Haematol"},{"issue":"2","key":"10.1016\/j.jtumed.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ddr.430270207","article-title":"Use of tissue plasminogen activator for rapid dissolution of fibrin and blood clots in the eye after surgery for glaucoma and cataract in humans","volume":"27","author":"Tripathi","year":"1992","journal-title":"Drug Dev Res"},{"issue":"2","key":"10.1016\/j.jtumed.2018.03.005_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0161-6420(96)30704-5","article-title":"Intracameral tissue plasmmogen activator after glaucoma surgery: indications, effectiveness, and complications","volume":"103","author":"Lundy","year":"1996","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.jtumed.2018.03.005_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bjo.82.7.810","article-title":"Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study","volume":"82","author":"Heiligenhaus","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtumed.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9394(99)00350-5","article-title":"Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis","volume":"129","author":"Skolnick","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtumed.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0008-4182(01)80020-X","article-title":"Tissue plasminogen activator for treatment of fibrin in endophthalmitis","volume":"36","author":"Damji","year":"2001","journal-title":"Can J Ophthalmology"},{"issue":"11","key":"10.1016\/j.jtumed.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.120.11.1487","article-title":"Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants","volume":"120","author":"Zalta","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtumed.2018.03.005_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.47102\/annals-acadmedsg.V35N10p723","article-title":"Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis","volume":"35","author":"Riaz","year":"2006","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"10.1016\/j.jtumed.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0161-6420(99)90165-3","article-title":"Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator","volume":"106","author":"Richard","year":"1999","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtumed.2018.03.005_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtumed.2018.03.005_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.01.003","article-title":"Acute central retinal artery occlusion treated with intravenous recombinant tissue plasminogen activator","volume":"21","author":"Nowak","year":"2012","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"Supplement C","key":"10.1016\/j.jtumed.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajoc.2017.07.002","article-title":"Reversal of cilioretinal artery occlusion with intra-arterial tissue plasminogen activator","volume":"7","author":"McClellan","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"12","key":"10.1016\/j.jtumed.2018.03.005_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jcma.2011.08.007","article-title":"Non-vitrectomizing vitreous surgery and adjuvant intravitreal tissue plasminogen activator for non-recent massive premacular hemorrhage","volume":"74","author":"Wu","year":"2011","journal-title":"J\u00a0Chin Med Assoc"},{"issue":"12","key":"10.1016\/j.jtumed.2018.03.005_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1607-551X(09)70514-5","article-title":"Intravitreous recombinant tissue plasminogen activator and gas to treat submacular hemorrhage in age-related macular degeneration","volume":"19","author":"Tsai","year":"2003","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"10.1016\/j.jtumed.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00186522","article-title":"The use of tissue plasminogen activator in post-traumatic total hyphaema","volume":"234","author":"Laatikainen","year":"1996","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtumed.2018.03.005_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.1991.01080050020010","article-title":"Lack of effectiveness of tissue plasminogen activator 20 or more days after vitrectomy","volume":"109","author":"Folk","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtumed.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s003470050457","article-title":"Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye","volume":"96","author":"Rehfeldt","year":"1999","journal-title":"Ophthalmologe"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361218300301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361218300301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T23:28:38Z","timestamp":1693610918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361218300301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1658361218300301"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2018.03.005","relation":{},"ISSN":["1658-3612"],"issn-type":[{"type":"print","value":"1658-3612"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of recombinant tissue plasminogen activator for treatment of recalcitrant anterior uveitis: A case series","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier Ltd on behalf of Taibah University.","name":"copyright","label":"Copyright"}]}}